Agenus share price logo

Agenus

NASDAQ: AGEN

Small Cap

$7.59

+0.37

(+5.12%)

Live

as on

Agenus Stock Performance

as on September 19, 2026 at 5:08 am IST

  • Day's Low

    Day's High

    $7.33
    $7.79
    downward going graph

    3.43%

    Downside

    2.64%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.71
    $8.85
    downward going graph

    64.30%

    Downside

    16.60%

    Upside

    downward going graph

Agenus share price movements today

Previous Close
$7.22
Open
$7.62
Volume
774.1K
Market Cap
$325.6M
Day's Low - High
$7.33 - $7.79
52 Week Low - High
$2.71 - $8.85

Agenus Historical Returns

1 Month Return
-4.12 %
3 Month Return
+ 140.67 %
1 Year Return
+ 58.68 %
3 Year Return
-71.12 %
5 Year Return
-93.81 %

Agenus Stock Fundamentals & Key Indicators

Check Agenus market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$325.6M

EPS (TTM)

2.7154

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

2.66

Industry PE ratio

-6.87

PEG Ratio

0.0007629712353904848

EBITDA

155.8M

Revenue (TTM)

132.7M

Profit Margin

75.63%

Return On Equity TTM

-38.12%

Agenus Stock Valuation

Track how Agenus P/E has moved over time to understand its valuation trends.

Agenus in the last 5 years

  • Overview

  • Trends

Lowest (-923.53x)

December 31, 2025

Today (-923.53x)

December 31, 2025

Industry (-6.87x)

December 31, 2025

Highest (-0.26x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -923.53x

Agenus vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Agenus with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$325.6M-93.81%2.6675.63%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Agenus Stock including INR - Dollar returns

The Agenus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Agenus investment value today

Current value as on today

₹1,82,264

Returns

₹82,264

(+82.26%)

Returns from Agenus Stock

₹66,813 (+66.81%)

Dollar Impact

₹15,451 (+15.45%)

Analyst Recommendation on Agenus Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Agenus. Average target price of $19.5

Agenus Share Price Target

Get share price movements and forecasts by analysts on Agenus.

What analysts predicted

61.08%UPSIDE

Target Price

$19.5

Current Price

$7.59

Analyzed by

2 Analysts

Target

$19.50

Agenus target price $19.5, a slight upside of 61.08% compared to current price of $7.59. According to 2 analysts rating.

Indian Investors' Interest in Agenus Stock

Search interest for Agenus Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Agenus Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
28
23
25
26
24
25
30
34
33
34
Gross Profit
24
-13
-16
-7
2
-1
5
26
33
34
Operating Income
-32
-30
-31
-25
-13
-16
-4
14
15
11
EBITDA
-30
-19
-28
-22
-10
-13
80
6
54
15
Interest Expense
29
31
35
20
12
13
13
16
14
15
Depreciation
3
3
3
3
3
3
3
0
0
0
Income Before Tax
-63
-54
-67
-46
-26
-30
63
-10
39
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-61
-53
-66
-45
-25
-27
63
-10
39
0
Net Profit Margin
87.57%
-56.90%
-64.08%
-26.29%
10.00%
-4.91%
19.83%
78.04%
98.27%
100.00%

Agenus Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
42
36
150
88
295
98
156
103
114
Gross Profit
-73
-87
-18
-56
113
-99
-81
-52
33
Operating Income
-103
-123
-70
-117
25
-179
-159
-120
-20
EBITDA
-95
-130
-63
-114
43
-161
-145
-101
62
Interest Expense
18
25
41
61
65
61
97
117
55
Depreciation
6
6
6
7
6
6
13
13
9
Income Before Tax
-120
-162
-111
-182
-28
-230
-257
-232
-3
Income Tax Expense
-
-12
-
-
-
-
-
-
-
Net Income
-120
-159
-107
-180
-23
-220
-245
-227
0
Net Profit Margin
-170.83%
-238.74%
-12.19%
-64.42%
38.42%
-101.24%
-52.05%
-50.79%
29.63%

Agenus Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-63
-54
-67
-45
-26
-30
63
-10
39
0
Operating Cash Flow
-38
-38
-53
-28
-25
-20
-14
-16
-35
-31
Investing Cash Flow
0
0
0
0
0
0
0
0
68
0
Financing Cash Flow
14
79
4
24
3
10
6
15
0
14
Change in Cash
-23
40
-48
-4
-21
-8
-7
0
31
-16

Agenus Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-120
-162
-111
-182
-28
-230
-257
-232
-232
Operating Cash Flow
-94
-131
-18
-139
10
-175
-224
-158
-158
Investing Cash Flow
2
-3
-4
-4
-43
-33
3
0
0
Financing Cash Flow
80
128
31
183
225
95
119
122
122
Change in Cash
-11
-7
8
40
192
-113
-101
-35
-35

Mutual Funds that own Agenus Stock

Check out the Mutual Funds with significant holdings in Agenus.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.129616%
1408966
TIAA-CREF Funds
2.24336%
1009970
VANGUARD HORIZON FUNDS
1.592953%
717154
Fidelity Concord Street Trust
0.646548%
291079
VANGUARD EXPLORER FUND
0.645587%
290646

Global Institutional Holdings in Agenus

Funds
Holdings
Vanguard
4.29%
iShares
3.43%
First Trust
0.41%
SPDR
0.21%
Invesco
0.08%

Agenus News & Key Events

  • img

    Today's Timeline - 13 July

    Tue, 07:04 AM

    -

    Agenus shares surged 82.69% after reporting positive Phase 1b data and announcing a $340 million private placement.

Insights on Agenus

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, AGEN stock has moved up by 140.7%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 33.73M → 34.51M (in $), with an average increase of 2.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 51.8% return, outperforming this stock by 122.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 521.1% return, outperforming this stock by 462.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 39.22M → -550.0K (in $), with an average decrease of 101.4% per quarter

About Agenus

Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.
OrganisationAgenus
Headquarters3 Forbes Road, Lexington, MA, United States, 02421-7305
IndustryBiotechnology
CEODr. Garo H. Armen Ph.D.
E-voting on sharesClick here to vote

Key Management of Agenus

Name

Title

Dr. Garo H. Armen Ph.D.

Founder, Interim CFO, Principal Financial Officer, CEO & Executive Chairman

Dr. Jennifer S. Buell Ph.D.

Director and President & CEO of MiNK Therapeutics

Craig Winter

Chief Information Officer

Mr. Zack Armen

Vice President of Investor Relations & Corporate Development

Ms. Stefanie Perna-Nacar

Chief Communications & Government Relations Officer

Ms. Tracy Mazza Clemente

Chief People Officer

Dr. Todd Jude Yancey M.D.

Member of Advisory Board & Chief Strategic Advisor

Dr. Steven J. O'Day M.D., Ph.D.

Chief Medical Officer

Dr. Robin G. Taylor M.B.A., Ph.D.

Chief Commercial Officer

Dr. Kamel Djazouli M.D.

Head of Medical Affairs

FAQs

What is Agenus share price today?

Agenus share price today is $7.59 as on . Agenus share today touched a day high of $7.79 and a low of $7.33.

What is the 52 week high and 52 week low for Agenus share?

Agenus share touched a 52 week high of $8.85 on and a 52 week low of $2.71 on . Agenus stock price today i.e. is trending at $7.59,which is 14.24% down from its 52 week high and 180.07% up from its 52 week low.

What is Agenus's market capitalisation today?

Agenus market capitalisation is $0.00T as on .

How to invest in Agenus Stock (AGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Agenus on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agenus Shares that will get you 0.1976 shares as per Agenus share price of $7.59 per share as on September 18, 2026 at 11:38 pm IST.

What is the minimum amount required to buy Agenus Stock (AGEN) from India?

Indian investors can start investing in Agenus (AGEN) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Agenus stock (as per the Rupee-Dollar exchange rate as on ). Based on Agenus share’s latest price of $7.59 as on September 18, 2026 at 11:38 pm IST, you will get 1.3175 shares of Agenus. Learn more about fractional shares .

What are the returns that Agenus has given to Indian investors in the last 5 years?

Agenus stock has given -93.81% share price returns and 29.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?